STEPS: Stepped Transition in Education Program for Students With ASD
Public ClinicalTrials.gov record NCT02468505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Young adults who have Autism Spectrum Disorder (ASD) without co-occurring intellectual impairment face a fairly unique set of challenges as they transition out of secondary school. These students are often quite capable of succeeding in higher education and many of them have interest in pursuing advanced degrees, but the nature of their disability and associated deficits (e.g., poor time management and poor self-regulation) may impede success. Individualized, appropriately timed, and developmentally sensitive transition and support services may promote optimal outcomes for these young people. The goal of this project is to develop a comprehensive program to promote successful transition of students with ASD from high school to post-secondary education.
Study identification
- NCT ID
- NCT02468505
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 25 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Jun 30, 2018
- Completion
- Sep 30, 2018
- Last update posted
- Jul 11, 2019
2014 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Virginia Polytechnic Institute and State University | Blacksburg | Virginia | 24061 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Autism Spectrum Disorder trials
Other public records listing Autism Spectrum Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07770152: Semaglutide in Youth With Autism Spectrum Disorder Not yet recruiting
- NCT07758088: Dance, Yoga, And Mindful Movement Training For ASD Not yet recruiting
- NCT07755137: Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical Settings Not yet recruiting
- NCT07746921: Smart Inhaler and Remote Asthma Management in Adolescents With Intellectual and Developmental Disabilities Not yet recruiting
- NCT05889273: ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD) Active, not recruiting
- NCT03827941: Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02468505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2019 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02468505 live on ClinicalTrials.gov.